3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
17
Oropharyngeal Neoplasms
11
Nasopharyngeal Carcinoma
11
Prostatic Neoplasms
7
Laryngeal Neoplasms
7
Mouth Neoplasms
6
Hypopharyngeal Neoplasms
6
Carcinoma
6
Rectal Neoplasms
5
Head and Neck Neoplasms
5
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Epstein-Barr Virus Infections
2
Astrocytoma
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomatitis
1
Stomach Neoplasms
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Sarcoma
1
Interventions
Temozolomide
7
Vincristine
5
Cyclophosphamide
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
cabozantinib
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
fludarabine
2
Topotecan
2
Radiation
2
Nuclear Medicine Department, Hospital
2
LY3023414
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Radiotherapy, Intensity-Modulated
×
90 days
×
Clear all
No trials found.